Fingerprint
Dive into the research topics of 'IGF1R protein expression is not associated with differential benefit to concurrent trastuzumab in early-stage HER2+ breast cancer from the North Central Cancer Treatment Group (Alliance) adjuvant trastuzumab trial N9831'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically